CY1109685T1 - Χρησιμοποιηση συμπλοκων ενωσεων σιδηρου(ιιι) - Google Patents

Χρησιμοποιηση συμπλοκων ενωσεων σιδηρου(ιιι)

Info

Publication number
CY1109685T1
CY1109685T1 CY20091101333T CY091101333T CY1109685T1 CY 1109685 T1 CY1109685 T1 CY 1109685T1 CY 20091101333 T CY20091101333 T CY 20091101333T CY 091101333 T CY091101333 T CY 091101333T CY 1109685 T1 CY1109685 T1 CY 1109685T1
Authority
CY
Cyprus
Prior art keywords
iii
iron compounds
complex iron
complex
carbohydrates
Prior art date
Application number
CY20091101333T
Other languages
English (en)
Inventor
Jessica Tanner-Baumgartner
Ranjeet Chandra
Peter Geisser
Original Assignee
Vifor (International) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor (International) Ag filed Critical Vifor (International) Ag
Publication of CY1109685T1 publication Critical patent/CY1109685T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά νέες θεραπευτικές εφαρμογές σύμπλοκων ενώσεων σιδήρου (III) με υδατάνθρακες ή παράγωγα τους, για την παρασκευή ενός φαρμάκου για τη βελτίωση της άμυνας του ανοσοποιητικού και/ή της εγκεφαλικής απόδοσης.
CY20091101333T 2005-02-09 2009-12-14 Χρησιμοποιηση συμπλοκων ενωσεων σιδηρου(ιιι) CY1109685T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100907 2005-02-09
EP06707742A EP1848446B1 (de) 2005-02-09 2006-01-18 Verwendung von eisen(iii)-komplexverbindungen

Publications (1)

Publication Number Publication Date
CY1109685T1 true CY1109685T1 (el) 2014-08-13

Family

ID=34938674

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101333T CY1109685T1 (el) 2005-02-09 2009-12-14 Χρησιμοποιηση συμπλοκων ενωσεων σιδηρου(ιιι)

Country Status (26)

Country Link
US (2) US8722101B2 (el)
EP (1) EP1848446B1 (el)
JP (1) JP5060312B2 (el)
KR (1) KR20070107106A (el)
CN (1) CN101155593A (el)
AT (1) ATE445406T1 (el)
AU (1) AU2006212322B2 (el)
BR (1) BRPI0606974A2 (el)
CA (1) CA2597154C (el)
CR (1) CR9300A (el)
CY (1) CY1109685T1 (el)
DE (1) DE502006005100D1 (el)
DK (1) DK1848446T3 (el)
ES (1) ES2333814T3 (el)
HR (1) HRP20100027T1 (el)
IL (1) IL185020A (el)
MX (1) MX2007009588A (el)
NO (1) NO20074536L (el)
PL (1) PL1848446T3 (el)
PT (1) PT1848446E (el)
RU (1) RU2359680C2 (el)
SI (1) SI1848446T1 (el)
TN (1) TNSN07307A1 (el)
UA (1) UA88347C2 (el)
WO (1) WO2006084782A1 (el)
ZA (1) ZA200707716B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
CN101365458B (zh) 2006-01-06 2012-09-05 卢特波尔德药品公司 用于铁给药的方法和组合物
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
NZ595597A (en) * 2009-03-25 2013-05-31 Pharmacosmos Holding As A stable iron oligosaccharide compound
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US11395502B2 (en) * 2012-10-18 2022-07-26 Patrick Monsivais Formulation for iron supplements
JP2016520538A (ja) * 2013-03-28 2016-07-14 ヴィフォー・インターナショナル・アーゲー 鉄欠乏症および鉄欠乏性貧血の治療および予防のためのＦｅ（ＩＩＩ）錯体
KR20150078375A (ko) * 2013-12-30 2015-07-08 한화케미칼 주식회사 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
FR3075001B1 (fr) * 2017-12-14 2021-09-10 Tereos Starch & Sweeteners Belgium Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
CN114288320A (zh) * 2021-12-29 2022-04-08 珠海天翼医药技术开发有限公司 一种猪用口服补铁剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3766165A (en) 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
DE4421159C1 (de) * 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
AU2002220280A1 (en) * 2000-12-07 2002-06-18 Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
WO2002083739A2 (en) 2001-04-10 2002-10-24 Danisco Usa, Inc. Polymerization of mono and disaccharides with monocarboxylic acids and lactones
CN1309741C (zh) 2002-04-09 2007-04-11 法玛科思莫斯控股有限公司 用于治疗缺铁性贫血的铁糊精化合物
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
KR20070107106A (ko) 2007-11-06
NO20074536L (no) 2007-11-05
ZA200707716B (en) 2008-06-25
RU2359680C2 (ru) 2009-06-27
RU2007133509A (ru) 2009-03-20
DK1848446T3 (da) 2010-02-15
HRP20100027T1 (hr) 2010-02-28
IL185020A (en) 2013-10-31
DE502006005100D1 (de) 2009-11-26
IL185020A0 (en) 2007-12-03
ATE445406T1 (de) 2009-10-15
AU2006212322B2 (en) 2012-01-19
PL1848446T3 (pl) 2010-03-31
CN101155593A (zh) 2008-04-02
PT1848446E (pt) 2009-12-21
CA2597154A1 (en) 2006-08-17
CA2597154C (en) 2011-03-15
WO2006084782A1 (de) 2006-08-17
MX2007009588A (es) 2007-09-12
JP5060312B2 (ja) 2012-10-31
EP1848446A1 (de) 2007-10-31
EP1848446B1 (de) 2009-10-14
UA88347C2 (ru) 2009-10-12
SI1848446T1 (sl) 2010-01-29
JP2008530049A (ja) 2008-08-07
US8722101B2 (en) 2014-05-13
CR9300A (es) 2007-12-07
BRPI0606974A2 (pt) 2009-07-28
US20080214496A1 (en) 2008-09-04
AU2006212322A1 (en) 2006-08-17
ES2333814T3 (es) 2010-03-01
TNSN07307A1 (en) 2008-12-31
US20140187514A1 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
CY1109685T1 (el) Χρησιμοποιηση συμπλοκων ενωσεων σιδηρου(ιιι)
ES2572329A2 (es) Combinacion de al menos dos agentes antivirales de accion directa y ribavirina pero no interferon, para uso en el tratamientodel vhc
BR112012018345A2 (pt) "compostos de heteroarila, bem como composições e usos dos mesmos"
TN2014000134A1 (en) Therapeutic peptides
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
EA201170703A1 (ru) Производные адамантилбензамида
TW200942524A (en) Novel aminomethyl benzene derivatives
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
EA201201623A1 (ru) Лечение диабета 2 типа
MX2013003060A (es) Terapia de combinacion para tratar infeccion por hcv.
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
MX2012007896A (es) Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
MX2013004906A (es) Nuevos inhibidores especificos de la proteasa ns3 de hcv.
EA201000392A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
ECSP10010711A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
EA200702590A1 (ru) Ингибиторы растворимой аденилатциклазы
WO2009008888A8 (en) African swine virus polypeptides as vaccines and its therapeutic use thereof
DK1962822T3 (da) Terapi af maligne neoplasier